Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $79,764.04 +4.72%
Ethereum $3,214.41 +5.95%
BNB $640.19 +3.23%
Optimism $1.72 +7.15%
Arbitrum $0.64 +8.26%
Solana $210.58 +6.82%
Polygon $0.41 +9.15%
Cosmos $5.42 +15.86%
Avalanche $32.52 +12.59%

Bitcoin $79,764.04 +4.72%
Ethereum $3,214.41 +5.95%
BNB $640.19 +3.23%
Optimism $1.72 +7.15%
Arbitrum $0.64 +8.26%
Solana $210.58 +6.82%
Polygon $0.41 +9.15%
Cosmos $5.42 +15.86%
Avalanche $32.52 +12.59%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed